Lincoln Pharmaceuticals Limited (LINCOLN.NS)

INR 873.9

(1.21%)

Long Term Debt Summary of Lincoln Pharmaceuticals Limited

  • Lincoln Pharmaceuticals Limited's latest annual long term debt in 2023 was - INR , up 100.0% from previous year.
  • Lincoln Pharmaceuticals Limited's latest quarterly long term debt in 2024 Q1 was - INR , down 0.0% from previous quarter.
  • Lincoln Pharmaceuticals Limited reported annual long term debt of -47.21 Million INR in 2022, down -4721100.0% from previous year.
  • Lincoln Pharmaceuticals Limited reported annual long term debt of -1000.00 INR in 2021, down -100.07% from previous year.
  • Lincoln Pharmaceuticals Limited reported quarterly long term debt of - INR for 2023 Q3, down 0.0% from previous quarter.
  • Lincoln Pharmaceuticals Limited reported quarterly long term debt of - INR for 2023 Q1, up 100.0% from previous quarter.

Annual Long Term Debt Chart of Lincoln Pharmaceuticals Limited (2023 - 2008)

Historical Annual Long Term Debt of Lincoln Pharmaceuticals Limited (2023 - 2008)

Year Long Term Debt Long Term Debt Growth
2023 - INR 100.0%
2022 -47.21 Million INR -4721100.0%
2021 -1000.00 INR -100.07%
2020 1.44 Million INR -91.46%
2019 16.92 Million INR -0.0%
2018 16.92 Million INR -75.57%
2017 69.26 Million INR -60.83%
2016 176.82 Million INR -25.15%
2015 236.23 Million INR -7.28%
2014 254.79 Million INR 32.46%
2013 192.35 Million INR 9.5%
2012 175.66 Million INR 1.96%
2011 172.28 Million INR -59.08%
2010 420.96 Million INR 41.36%
2009 297.8 Million INR 91.14%
2008 155.8 Million INR 0.0%

Peer Long Term Debt Comparison of Lincoln Pharmaceuticals Limited

Name Long Term Debt Long Term Debt Difference
Sigachi Industries Limited 265.79 Million INR 100.0%
Ind-Swift Limited 10.09 Billion INR 100.0%
Bajaj HealthCare Limited 650.34 Million INR 100.0%
Sakar Healthcare Limited 549.55 Million INR 100.0%
Aurobindo Pharma Limited 21.34 Billion INR 100.0%
Innova Captab Limited 2.1 Billion INR 100.0%
Divi's Laboratories Limited 20 Million INR 100.0%
AstraZeneca Pharma India Limited 27.83 Million INR 100.0%
Morepen Laboratories Limited 33.64 Million INR 100.0%
Mankind Pharma Limited 325.81 Million INR 100.0%
Sequent Scientific Limited 1.42 Billion INR 100.0%
Wanbury Limited 820 Million INR 100.0%
Laurus Labs Limited 7.98 Billion INR 100.0%
Nectar Lifesciences Limited 1.4 Billion INR 100.0%
Glenmark Life Sciences Limited 147.61 Million INR 100.0%
Alembic Limited 73.9 Million INR 100.0%
Hikal Limited 4.22 Billion INR 100.0%
Alembic Pharmaceuticals Limited 628.8 Million INR 100.0%
Neuland Laboratories Limited 449.2 Million INR 100.0%
J. B. Chemicals & Pharmaceuticals Limited 236.4 Million INR 100.0%
Glenmark Pharmaceuticals Limited 1.51 Billion INR 100.0%
IOL Chemicals and Pharmaceuticals Limited - INR NaN%
Themis Medicare Limited 267.74 Million INR 100.0%
RPG Life Sciences Limited -30.3 Million INR 100.0%
Zydus Lifesciences Limited 251 Million INR 100.0%
Lupin Limited 1.55 Billion INR 100.0%
Amrutanjan Health Care Limited 13.96 Million INR 100.0%
Wockhardt Limited 8.91 Billion INR 100.0%
Vaishali Pharma Limited 35.98 Million INR 100.0%
Aarti Pharmalabs Limited 400 Thousand INR 100.0%
Jagsonpal Pharmaceuticals Limited 75.57 Million INR 100.0%
Jubilant Pharmova Limited 31.67 Billion INR 100.0%
FDC Limited 2.46 Million INR 100.0%
Dr. Reddy's Laboratories Limited 5.99 Billion INR 100.0%
Kilitch Drugs (India) Limited - INR NaN%
Eris Lifesciences Limited 6.54 Billion INR 100.0%
Venus Remedies Limited 386.8 Million INR 100.0%
ZIM Laboratories Limited 356 Million INR 100.0%
Bliss GVS Pharma Limited 355.92 Million INR 100.0%
Par Drugs and Chemicals Limited - INR NaN%
Caplin Point Laboratories Limited 9.2 Million INR 100.0%
Shilpa Medicare Limited 5.6 Billion INR 100.0%
Albert David Limited 6.01 Million INR 100.0%
Ajanta Pharma Limited 235.2 Million INR 100.0%
Hester Biosciences Limited 1.81 Billion INR 100.0%
Suven Pharmaceuticals Limited 212.35 Million INR 100.0%
Solara Active Pharma Sciences Limited 1.17 Billion INR 100.0%
Gufic Biosciences Limited 1.53 Billion INR 100.0%
Windlas Biotech Limited 20.18 Million INR 100.0%
Procter & Gamble Health Limited 68.8 Million INR 100.0%
Aarey Drugs & Pharmaceuticals Limited 32.24 Million INR 100.0%
Mangalam Drugs & Organics Limited 133.54 Million INR 100.0%
Granules India Limited 689.71 Million INR 100.0%
Aarti Drugs Limited 2.75 Billion INR 100.0%
Bal Pharma Limited 363.82 Million INR 100.0%
Alkem Laboratories Limited 400 Million INR 100.0%
Sun Pharmaceutical Industries Limited 13.3 Million INR 100.0%
Medicamen Biotech Limited 12.55 Million INR 100.0%
Unichem Laboratories Limited 382.22 Million INR 100.0%
Bafna Pharmaceuticals Limited 107.53 Million INR 100.0%
Biofil Chemicals and Pharmaceuticals Limited - INR NaN%
Valiant Laboratories Limited 750.89 Million INR 100.0%
Orchid Pharma Limited 1.2 Billion INR 100.0%
Medico Remedies Limited 8.67 Million INR 100.0%
Ind-Swift Laboratories Limited 111.62 Million INR 100.0%
Ipca Laboratories Limited 5.8 Billion INR 100.0%
Brooks Laboratories Limited 3.56 Million INR 100.0%
Syncom Formulations (India) Limited -1.21 Million INR 100.0%
Piramal Enterprises Limited 535.85 Billion INR 100.0%
Torrent Pharmaceuticals Limited 16.04 Billion INR 100.0%
NATCO Pharma Limited 53 Million INR 100.0%
Suven Life Sciences Limited - INR NaN%
Krebs Biochemicals & Industries Limited 1.83 Billion INR 100.0%
Strides Pharma Science Limited 6.71 Billion INR 100.0%
Indoco Remedies Limited 3.51 Billion INR 100.0%
Alpa Laboratories Limited - INR NaN%
Lasa Supergenerics Limited - INR NaN%
Sun Pharma Advanced Research Company Limited 106.6 Million INR 100.0%